SEC Form 4 · accession 0001140361-15-045303
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Koenig
Officer — President and CEO · Director
Period of report
Dec 18, 2015
Accepted (ET)
Dec 22, 2015 · 1:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $31.43 | Dec 18, 2015 | A | 150,000 | A | — | Dec 18, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F112.5% of the option becomes exercisable on June 18, 2016 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.